# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3405144 | A | Drug metabolism in Sprague-Dawley rat liver S9 fraction assessed as compound remaining at 1 uM after 30 mins by HPLC/MS/MS analysis relative to control | Rattus norvegicus | 12 | subcellular format | Scientific Literature | ||
2. | ALA3405145 | A | Drug metabolism in rat serum assessed as compound remaining at 1 uM after 30 mins by HPLC/MS/MS analysis relative to control | Rattus norvegicus | 12 | cell-free format | Scientific Literature | ||
3. | ALA3405146 | A | Drug metabolism in human liver S9 fraction assessed as compound remaining at 1 uM after 30 mins by HPLC/MS/MS analysis relative to control | Homo sapiens | 12 | subcellular format | Scientific Literature | ||
4. | ALA3405147 | A | Drug metabolism in human serum assessed as compound remaining at 1 uM after 30 mins by HPLC/MS/MS analysis relative to control | Homo sapiens | 12 | cell-free format | Scientific Literature | ||
5. | ALA3405148 | A | Drug metabolism in Sprague-Dawley rat liver S9 fraction assessed as 2-(3-aminopiperidin-1-yl)-3-(2-chlorobenzyl)-5-methyl-4-oxo-4,5-dihydro-3H-imidazo[4,5-c]quinoline-8-carboxylic acid formation at 1 uM after 30 mins by HPLC/MS/MS analysis relative to control | Rattus norvegicus | 9 | subcellular format | Scientific Literature | ||
6. | ALA3405151 | A | Drug metabolism in rat serum assessed as 2-(3-aminopiperidin-1-yl)-3-(2-chlorobenzyl)-5-methyl-4-oxo-4,5-dihydro-3H-imidazo[4,5-c]quinoline-8-carboxylic acid formation at 1 uM after 30 mins by HPLC/MS/MS analysis relative to control | Rattus norvegicus | 9 | cell-free format | Scientific Literature | ||
7. | ALA3405154 | A | Drug metabolism in human liver S9 fraction assessed as 2-(3-aminopiperidin-1-yl)-3-(2-chlorobenzyl)-5-methyl-4-oxo-4,5-dihydro-3H-imidazo[4,5-c]quinoline-8-carboxylic acid formation at 1 uM after 30 mins by HPLC/MS/MS analysis relative to control | Homo sapiens | 9 | subcellular format | Scientific Literature | ||
8. | ALA3405157 | A | Drug metabolism in human serum assessed as 2-(3-aminopiperidin-1-yl)-3-(2-chlorobenzyl)-5-methyl-4-oxo-4,5-dihydro-3H-imidazo[4,5-c]quinoline-8-carboxylic acid formation at 1 uM after 30 mins by HPLC/MS/MS analysis relative to control | Homo sapiens | 9 | cell-free format | Scientific Literature | ||
9. | ALA3405160 | A | Permeability of the compound at pH 5 by PAMPA | 14 | assay format | Scientific Literature | |||
10. | ALA3405161 | A | Permeability of the compound at pH 7.4 by PAMPA | 14 | assay format | Scientific Literature |